|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$82,119,756 |
|
|
Indirect Value
|
$12,961,771,173 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,043,890,929 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 44 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SGEN |
Seagen Inc |
Director |
|
2011-02-02 |
4 |
B |
$15.50 |
$747,054 |
I/I |
48,197 |
303,449 |
2.25 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-07 |
4 |
S |
$12.66 |
$617,006 |
I/I |
(48,744) |
1,151,014 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2006-06-20 |
4 |
B |
$3.99 |
$194,796 |
I/I |
48,776 |
3,128,208 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2011-12-30 |
4 |
OE |
$6.25 |
$309,769 |
I/I |
49,563 |
450,461 |
0 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2008-03-13 |
4 |
B |
$8.69 |
$435,755 |
I/I |
50,130 |
5,002,636 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-03-04 |
4 |
B |
$25.44 |
$1,282,845 |
I/I |
50,400 |
5,304,082 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-02-23 |
4 |
B |
$22.87 |
$1,160,710 |
I/I |
50,735 |
4,985,725 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-03-09 |
4 |
B |
$26.17 |
$1,333,262 |
I/I |
50,856 |
5,654,104 |
2.25 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2010-04-27 |
4 |
B |
$2.06 |
$106,340 |
I/I |
51,172 |
5,529,735 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2009-05-11 |
4 |
B |
$19.36 |
$1,007,294 |
I/I |
51,710 |
3,629,658 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2010-05-10 |
4 |
S |
$12.70 |
$666,930 |
I/I |
(52,508) |
248,829 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2006-02-24 |
4 |
B |
$3.35 |
$176,414 |
I/I |
52,661 |
88,559 |
1.5 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2016-01-20 |
4 |
B |
$6.87 |
$362,171 |
I/I |
52,695 |
12,446,380 |
1.5 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-03-18 |
4 |
B |
$8.02 |
$423,038 |
I/I |
52,736 |
7,937,438 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-05-04 |
4 |
B |
$27.99 |
$1,488,643 |
I/I |
53,128 |
229,149 |
2.25 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-01-08 |
4 |
B |
$7.21 |
$392,821 |
I/I |
54,470 |
2,333,245 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-05-31 |
4 |
B |
$27.46 |
$1,512,235 |
I/I |
55,039 |
5,784,326 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-05-27 |
4 |
B |
$27.04 |
$1,491,922 |
I/I |
55,183 |
5,729,287 |
2.25 |
- |
|
KOD |
Kodiak Sciences Inc. |
Director |
|
2022-01-28 |
4 |
B |
$49.70 |
$2,786,084 |
I/I |
55,258 |
14,336,671 |
2.25 |
% |
|
GHDX |
Genomic Health Inc |
Director |
|
2010-08-19 |
4 |
B |
$14.56 |
$808,993 |
I/I |
55,305 |
4,645,388 |
2.25 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2006-12-22 |
4 |
B |
$3.85 |
$213,266 |
I/I |
55,378 |
543,012 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-14 |
4 |
B |
$28.44 |
$1,586,898 |
I/I |
55,804 |
7,375,422 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-11-04 |
4 |
B |
$25.78 |
$1,441,461 |
I/I |
55,920 |
6,143,870 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-09 |
4 |
B |
$26.24 |
$1,473,628 |
I/I |
55,994 |
7,159,786 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2009-05-07 |
4 |
B |
$19.53 |
$1,100,566 |
I/I |
56,325 |
3,548,517 |
2.25 |
- |
|
1397 Records found
|
|
Page 44 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|